Introduction and Objectives Obstructive sleep apnoea (OSA) is often undiagnosed and hence untreated. Its prevalence is ever increasing given the escalating obesity of the population. Apnoea/hypopnoea index (AHI) is commonly used to diagnose and classify the severity of OSA. The overnight oximetry, which measures oxygen desaturation index (ODI), is far simpler to measure than a full respiratory polysomnography, but its diagnostic accuracy at predicting OSA has not been formally established. We proposed that in patients with morbid obesity (BMI 40), the diagnostic accuracy for establishing an OSA diagnosis using ODI is as effective as AHI. Discussion The data provided by a respiratory polysomnography test provides a range of parameters, but polysomnography is resource intensive and requires significant time and expertise to assess properly. SIGN guidance states that oximetry can positively diagnose OSA but cannot exclude it. 1 There are multiple benefits to having a simple tool that can identify high-risk individuals that may suffer with OSA including early diagnosis and reduced cost as well as resource utilisation. This is likely to improve patient care with earlier diagnosis and treatment of OSA. Overnight oximetry can safely diagnose OSA in morbidly obese patients. This has the potential to optimise efficiency and reduce cost without impacting patient care.
